{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:33:49Z","timestamp":1789418029318,"version":"build-2803163510"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:00:00Z","timestamp":1491436800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:00:00Z","timestamp":1491436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Robert Kruger Research Fund"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA06927"],"award-info":[{"award-number":["CA06927"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12967-017-1178-8","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T12:17:50Z","timestamp":1491481070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Combination of serum histidine and plasma tryptophan as a potential biomarker to detect clear cell renal cell carcinoma"],"prefix":"10.1186","volume":"15","author":[{"given":"Hyung-Ok","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Uzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Kister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4990-3695","authenticated-orcid":false,"given":"Warren D.","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"key":"1178_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"1178_CR2","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1200\/JCO.2002.05.111","volume":"20","author":"A Zisman","year":"2002","unstructured":"Zisman A, Pantuck AJ, Wieder J, Chao DH, Dorey F, Said JW, deKernion JB, Figlin RA, Belldegrun AS. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol. 2002;20:4559\u201366.","journal-title":"J Clin Oncol"},{"key":"1178_CR3","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.juro.2011.05.085","volume":"186","author":"A Mustafa","year":"2011","unstructured":"Mustafa A, Gupta S, Hudes GR, Egleston BL, Uzzo RG, Kruger WD. Serum amino Acid levels as a biomarker for renal cell carcinoma. J Urol. 2011;186:1206\u201312.","journal-title":"J Urol"},{"key":"1178_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrurol.2010.47","volume":"7","author":"WM Linehan","year":"2010","unstructured":"Linehan WM, Srinivasan R, Schmidt LS. The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol. 2010;7:277\u201385.","journal-title":"Nat Rev Urol"},{"key":"1178_CR5","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/01.RES.0000129182.46440.4a","volume":"94","author":"L Wang","year":"2004","unstructured":"Wang L, Jhee KH, Hua X, DiBello PM, Jacobsen DW, Kruger WD. Modulation of cystathionine beta-synthase level regulates total serum homocysteine in mice. Circ Res. 2004;94:1318\u201324.","journal-title":"Circ Res"},{"key":"1178_CR6","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/clinchem\/44.5.1052","volume":"44","author":"CK Chuang","year":"1998","unstructured":"Chuang CK, Lin SP, Lin YT, Huang FY. Effects of anticoagulants in amino acid analysis: comparisons of heparin, EDTA, and sodium citrate in vacutainer tubes for plasma preparation. Clin Chem. 1998;44:1052\u20136.","journal-title":"Clin Chem"},{"key":"1178_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1161\/01.ATV.5.1.2","volume":"5","author":"MB Zucker","year":"1985","unstructured":"Zucker MB, Nachmias VT. Platelet activation. Arteriosclerosis. 1985;5:2\u201318.","journal-title":"Arteriosclerosis"},{"key":"1178_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.molmed.2012.05.007","volume":"18","author":"A Efeyan","year":"2012","unstructured":"Efeyan A, Zoncu R, Sabatini DM. Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med. 2012;18:524\u201333.","journal-title":"Trends Mol Med"},{"key":"1178_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1123\/ijsnem.22.6.452","volume":"22","author":"LM Burke","year":"2012","unstructured":"Burke LM, Winter JA, Cameron-Smith D, Enslen M, Farnfield M, Decombaz J. Effect of intake of different dietary protein sources on plasma amino acid profiles at rest and after exercise. Int J Sport Nutr Exerc Metab. 2012;22:452\u201362.","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"1178_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0026-0495(79)90101-X","volume":"28","author":"JP Milsom","year":"1979","unstructured":"Milsom JP, Morgan MY, Sherlock S. Factors affecting plasma amino acid concentrations in control subjects. Metabolism. 1979;28:313\u20139.","journal-title":"Metabolism"},{"key":"1178_CR11","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/bjc.2013.443","volume":"109","author":"M Pichler","year":"2013","unstructured":"Pichler M, Hutterer GC, Stojakovic T, Mannweiler S, Pummer K, Zigeuner R. High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients. Br J Cancer. 2013;109:1123\u20139.","journal-title":"Br J Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-017-1178-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-017-1178-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-017-1178-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:52:59Z","timestamp":1589536379000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-017-1178-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,6]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1178"],"URL":"https:\/\/doi.org\/10.1186\/s12967-017-1178-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,6]]},"assertion":[{"value":"19 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"72"}}